Gabriele Missale - Infectious Diseases

Author Information

Gabriele Missale is affiliated with the Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology, at the Azienda-Ospedaliero-Universitaria di Parma, located in Parma, Italy. This affiliation suggests a focus on infectious diseases and hepatology, indicating a strong foundation in both clinical and research aspects of viral pathologies.

Research Contributions

Gabriele Missale has significantly contributed to the field of hepatology, with a particular emphasis on hepatocellular carcinoma and viral infections. The research work includes exploring prognostic systems for hepatocellular carcinoma, understanding the role of androgen receptors in breast cancer, and the impact of socio-economic factors on cancer management. Additionally, Missale's work extends to the study of immune cell dynamics in liver diseases and the development of assays for viral infections, such as a simplified SARS-CoV-2 pseudovirus neutralization assay. This diverse research portfolio highlights a commitment to understanding complex disease mechanisms and improving clinical outcomes.

Aliases

The author is known by several aliases, including G Missale, G. Missale, and Gabriele Missale. The most appropriate and formal name for academic and professional references is Gabriele Missale.

Publication and Citation Metrics

Metric	Value
Total Citation Count	12,942
h-index	58
Total Number of Papers	241

Publications:

Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.

DOI: 10.1016/j.dld.2022.03.002

Year: 2022

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

DOI: 10.3390/cancers13071673

Year: 2021

Abstract PS4-33: Androgen receptors are highly expressed in HER2-positive breast cancers that achieve pCR to anti-HER2 monoclonal antibodies

DOI: 10.1158/1538-7445.SABCS20-PS4-33

Year: 2021

Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

DOI: 10.1002/lci2.33

Year: 2021

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.

DOI: 10.1016/j.ejca.2021.09.018

Year: 2021

Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics

DOI: 10.1007/s00261-021-03183-9

Year: 2021

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma

DOI: 10.3390/cells10030614

Year: 2021

Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C

DOI: 10.3390/cells10102563

Year: 2021

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay

DOI: 10.3390/vaccines9040389

Year: 2021

Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter

DOI: 10.1177/1724600821996372

Year: 2021

Can Aspirin Be Used for Fever Management?

How Does Personalized Medicine Apply to Infectious Diseases?

What are Some Natural Alternatives to Chemical Insect Repellents?

What is Protein Targeting?

How do Bacteria Cause Diseases?

What Does the Future Hold for Personalized Medicine in Infectious Diseases?

What Are Some Current Research Directions?

How Does Immunotherapy Work?

How Do Airborne Diseases Differ from Droplet Transmission?

What are the Symptoms of Gonorrhea?

Partnered Content Networks

Relevant Topics